Speculating in Takeover Targets Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Speculating in Takeover Targets

ULBI 5.680

-9.0%

Nov 11 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: richardred who wrote (979)	1/24/2006 12:33:27 PM
From: richardred	Read Replies (1) of 7243

Cytori Gets EU OK for Stem Cell Machine Tuesday January 24, 10:55 am ET Cytori Therapeutics Gets European Approval to Sell Stem Cell Processor SAN DIEGO (AP) -- Cytori Therapeutics Inc. said Tuesday that European regulators approved its stem cell processing device for sale, triggering an $11 million payment to Cytori from the joint venture it operates with Tokyo's Olympus Corp. The two companies joined up in November to collaborate on regenerative medicine products. The recently approved Celution System processes adult stem cells from fat tissue in about an hour, making these important regenerative cells available for re-implantation into a patient during a surgical procedure. Cytori shares rose 1 cent to $7.05 in recent Nasdaq trading. Olympus, which makes cameras and electronics along with microscopes and measuring equipment, trades over the counter in the United States. biz.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next